wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q43195843-F35BD0E6-9774-44D9-A6BF-F7F6294B379C
Q43195843-F35BD0E6-9774-44D9-A6BF-F7F6294B379C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43195843-F35BD0E6-9774-44D9-A6BF-F7F6294B379C
Clinical activity of the mutant-selective EGFR inhibitor AZD9291 in patients with EGFR inhibitor-resistant non-small cell lung cancer.
P2860
Q43195843-F35BD0E6-9774-44D9-A6BF-F7F6294B379C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43195843-F35BD0E6-9774-44D9-A6BF-F7F6294B379C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
de05a3cf1ab01aefd1232bf36a092a4b359ae2c6
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.